Frontlight ResearchEarly access
Metastatic breast cancer trials in United Arab Emirates
2 trials · From ClinicalTrials.gov, checked 18 November 2026. Ask the study team whether a trial fits you.
- Phase 3Not yet taking people in United Arab EmiratesA Phase IIIb Study to Evaluate Camizestrant Plus Ribociclib in ER-positive, HER2-negative Advanced Breast Cancer
- Where
- Abu Dhabi, Al Ain City, Dubai, Mohammed Bin Zayed City
- Age
- 18 years to 130 years
- People
- 150 worldwide
- Run by
- AstraZeneca
See details and how to joinNCT07647328 - No phaseNot yet taking people in United Arab EmiratesBEYOND Study: A Multicentre, Prospective, Observational Study of Real-world Treatment Patterns and Outcomes of Trastuzumab Deruxtecan in Patients With HR Positive, HER2-low or Ultra-low Metastatic Breast Cancer Previously Treated With Endocrine Therapy
- Where
- Abu Dhabi, Al Ain City, Dubai
- Age
- 18 years and over
- People
- 109 worldwide
- Run by
- AstraZeneca
See details and how to joinNCT07597993